Login
$HAFG
$0.40 +$0.00 (0.0%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
CURRENT ASSETS
Cash and cash equivalents
Account receivable, net
Related Party
Total account receivable, net
Deposits, prepayments and other receivables
Due from a related party
Advance to supplier
Total Current Assets
NON-CURRENT ASSETS
Deferred tax assets, net
Operating lease right-of-use assets
Total Non Current Assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ DEFICIT
CURRENT LIABILITIES
Accounts payable
Advance from customers
Other payables
Due to related parties
Tax payable
Total current liabilities
TOTAL LIABILITIES
SHAREHOLDERS’ DEFICIT
Preferred Stock
Series A Convertible Preferred Stock
Series L Preferred stock
Common stock - 600,000,000 shares authorized, par value $0.001, 74,228,185 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Total shareholders’ deficit
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support